| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |